US Broker Ratings

Glaukos Corporation (GKOS): Investor Outlook Reveals Strong Buy Ratings and 23% Potential Upside

Glaukos Corporation (NYSE: GKOS), a leading player in the healthcare sector specializing in medical devices, has captured the attention of investors with its promising growth trajectory and robust analyst ratings...

Encompass Health Corporation (EHC) Stock Analysis: Exploring a 46.55% Potential Upside

Encompass Health Corporation (NYSE: EHC) stands as a prominent player in the healthcare sector, specifically within the medical care facilities industry. This Birmingham, Alabama-based company operates a network of inpatient..

Align Technology, Inc. (ALGN) Stock Analysis: Exploring a Promising 18.23% Upside Potential

Align Technology, Inc. (NASDAQ: ALGN), a leader in the healthcare sector’s medical instruments and supplies industry, has been capturing investor attention with its innovative approach to orthodontic solutions and a..

Zoetis Inc. (ZTS) Stock Analysis: Potential 28% Upside Attracts Investor Attention

Zoetis Inc. (NYSE: ZTS), a leader in the animal health industry, attracts investor interest with a market capitalization of $51.98 billion and an impressive potential upside of 28.03% based on..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: A 25.73% Potential Upside Beckons Investors

Teva Pharmaceutical Industries Limited (NYSE: TEVA), an established player in the healthcare sector, is poised to capture investor attention with a noteworthy potential upside of 25.73%, as indicated by its..

Elanco Animal Health (ELAN) Stock Analysis: Unpacking a 24.65% Potential Upside for Investors

Elanco Animal Health Incorporated (NASDAQ: ELAN) stands out in the healthcare sector as a key player in the animal health industry. With a market capitalization of $11.47 billion, Elanco is..

Revvity, Inc. (RVTY) Stock Analysis: Exploring a 33.72% Potential Upside for Investors

Revvity, Inc. (NYSE: RVTY) is making waves in the healthcare sector, particularly within the diagnostics and research industry. Formerly known as PerkinElmer, Inc., the company rebranded in April 2023, continuing..

argenx SE (ARGX) Stock Analysis: A 36% Potential Upside Beckons in the Biotech Sector

For investors eyeing opportunities in the booming biotechnology sector, argenx SE (NASDAQ: ARGX) presents a compelling case. With a market capitalization of $46.32 billion, this Netherlands-based biopharmaceutical company specializes in..

Masimo Corporation (MASI) Stock Analysis: Evaluating Growth and Market Position in the Healthcare Sector

Masimo Corporation (NASDAQ: MASI) remains a noteworthy player in the healthcare sector, specifically within the medical devices industry. Based in Irvine, California, Masimo specializes in patient monitoring technologies and connectivity..

Doximity, Inc. (DOCS) Stock Analysis: Exploring a Potential 73.67% Upside in the Healthcare Sector

Doximity, Inc. (NYSE: DOCS), a prominent player in the healthcare information services industry, offers digital tools that empower medical professionals across the United States. With a market capitalization of $4.29..

BioMarin Pharmaceutical Inc. (BMRN) Investor Outlook: Exploring a 60.13% Potential Upside

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a key player in the biotechnology sector, is making headlines with its impressive growth potential. With a market capitalization of $10.67 billion, BioMarin focuses on..

Henry Schein, Inc. (HSIC) Investor Outlook: Exploring a Potential 21.72% Upside in the Healthcare Sector

Henry Schein, Inc. (HSIC), a stalwart in the healthcare sector, has carved a niche in the medical distribution industry, providing a comprehensive array of health care products and services to..

Guardant Health, Inc. (GH) Investor Outlook: A 39% Potential Upside Beckons

Guardant Health, Inc. (NASDAQ: GH) is making waves in the healthcare sector with its innovative approach to precision oncology. Specializing in diagnostics and research, this Palo Alto-based company is carving..

BeOne Medicines Ltd. (ONC): A Swiss Biotech Powerhouse with 31% Upside Potential

BeOne Medicines Ltd. (ONC), a prominent player in the global biotechnology sector, is capturing significant attention in the investment community. Based in Basel, Switzerland, this oncology-focused company has been making..

Insmed Incorporated (INSM) Stock Analysis: A Biotech Pioneer with 31.94% Potential Upside

Insmed Incorporated (NASDAQ: INSM) stands out in the biotechnology sector with its focus on developing therapies for serious and rare diseases. As the company continues its journey in the healthcare..

Takeda Pharmaceutical Company L (TAK): Investor Outlook Reveals 9.63% Potential Upside and Strong Buy Ratings

Takeda Pharmaceutical Company Limited (NYSE: TAK), a titan in the healthcare sector and a prominent player in the specialty and generic drug manufacturing industry, presents a compelling investment case for..

Baxter International Inc. (BAX) Stock Analysis: Exploring a 33% Potential Upside in the Healthcare Sector

Investors looking to diversify their portfolios with a solid player in the healthcare sector might find Baxter International Inc. (NYSE: BAX) an interesting prospect. With a market capitalization of $8.61..

Corcept Therapeutics (CORT): Investor Outlook Highlights Strong Upside Potential Amidst Robust Growth

Corcept Therapeutics Incorporated (NASDAQ: CORT) is capturing the attention of investors with its promising growth trajectory and significant upside potential. As a key player in the biotechnology sector, the company..

Alnylam Pharmaceuticals (ALNY) Stock Analysis: Biotechnology Powerhouse With a 40.92% Potential Upside

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leader in the biotechnology sector, has captured investor attention with its cutting-edge therapeutics based on ribonucleic acid interference (RNAi). With a market capitalization of..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Promising Growth Potential with a 24.85% Upside

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), a leading biotechnology company, has garnered significant attention in the healthcare sector. With a market capitalization of $111.45 billion, Vertex stands as a formidable player..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds